We are live on ! Find out more
STML

Stemline Therapeutics, Inc.
STML

Delisted

STML was delisted on the 9th of June, 2020.

Back to rankings

94 hedge funds and large institutions have $194M invested in Stemline Therapeutics, Inc. in 2020 Q1 according to their latest regulatory filings, with 17 funds opening new positions, 36 increasing their positions, 25 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 25

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less funds holding

Funds holding: 99 → 94 (-5)

15% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 20

57% less capital invested

Capital invested by funds: $449M → $194M (-$255M)

79% less call options, than puts

Call options by funds: $80K | Put options by funds: $388K

Holders
94
Holders Change
-5
Holders Change %
-5.05%
% of All Funds
2.07%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
17
Increased
36
Reduced
25
Closed
20
Calls
$80K
Puts
$388K
Net Calls
-$308K
Net Calls Change
+$9K

Top Buyers

Rank Fund Capital Flow
1
CC
Clearline Capital
New York
+$6.92M
2
SSA
Schonfeld Strategic Advisors
New York
+$6.06M
3
SCM
Stonepine Capital Management
Oregon
+$5.75M
4
Goldman Sachs
Goldman Sachs
New York
+$3.58M
5
ELI
Empire Life Investments
Ontario, Canada
+$2.39M

Top Sellers

Rank Fund Capital Flow
1
AllianceBernstein
AllianceBernstein
Tennessee
-$11.7M
2
SAM
Sectoral Asset Management
Quebec, Canada
-$10.9M
3
IBT
International Biotechnology Trust
United Kingdom
-$10.3M
4
Axa
Axa
France
-$6.2M
5
PC
Polar Capital
United Kingdom
-$4.43M
Name Holding Trade Value Shares
Change 		Change in
Stake
CI
26
Cambiar Investors
Colorado
$886K +$1.19M +183,102 New
Renaissance Technologies
27
Renaissance Technologies
New York
$766K +$1.03M +158,213 New
N
28
Nuveen
North Carolina
$713K -$2.79K -430 -0.3%
CC
29
Carlson Capital
Texas
$621K -$862K -133,000 -51%
Victory Capital Management
30
Victory Capital Management
Texas
$616K +$368K +56,775 +81%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$494K +$118K +18,232 +22%
Ameriprise
32
Ameriprise
Minnesota
$479K +$185K +28,600 +41%
DMK
33
David M. Knott
$435K -$361K -55,611 -38%
Citadel Advisors
34
Citadel Advisors
Florida
$429K -$4.13M -636,786 -88%
Swiss National Bank
35
Swiss National Bank
Switzerland
$423K +$23.3K +3,600 +4%
Los Angeles Capital Management
36
Los Angeles Capital Management
California
$415K +$314K +48,470 +130%
WMSA
37
Weiss Multi-Strategy Advisers
New York
$396K +$303K +46,770 +134%
State of Wisconsin Investment Board
38
State of Wisconsin Investment Board
Wisconsin
$382K +$122K +18,800 +31%
CS
39
Credit Suisse
Switzerland
$353K -$53.7K -8,290 -10%
AllianceBernstein
40
AllianceBernstein
Tennessee
$346K -$11.7M -1,812,018 -96%
California State Teachers Retirement System (CalSTRS)
41
California State Teachers Retirement System (CalSTRS)
California
$342K +$5.3K +818 +1%
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
$286K +$222K +34,245 +137%
VEA
43
Virtus ETF Advisers
New York
$283K -$32K -4,940 -8%
RhumbLine Advisers
44
RhumbLine Advisers
Massachusetts
$273K – – –
Allianz Asset Management
45
Allianz Asset Management
Germany
$256K -$4.67K -720 -1%
VFA
46
Values First Advisors
Tennessee
$252K +$130K +19,983 +62%
Russell Investments Group
47
Russell Investments Group
United Kingdom
$245K +$331K +51,016 New
Citigroup
48
Citigroup
New York
$203K +$201K +31,036 +282%
UBS AM
49
UBS AM
Illinois
$188K -$1.9K -293 -0.7%
LI
50
Leap Investments
Illinois
$187K +$251K +38,700 New
1
2
3 4 5

STML Hedge Fund Activity: Q1 2020 in Review

94 of the 4,538 institutional investors tracked by Wall St. Rank reported a position in Stemline Therapeutics, Inc. (STML) for Q1 2020, worth a combined $194M — down 57% from $449M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of STML and 17 opened new positions — a net loss of 3 holders — while 25 trimmed existing stakes and 36 added.

The largest buyer was Clearline Capital, adding an estimated $6.92M. The largest seller was AllianceBernstein, cutting an estimated $11.7M.

  • 94 institutional investors held Stemline Therapeutics, Inc. (STML) as of Q1 2020, down from 99 in Q4 2019.
  • Funds reported $194M of Stemline Therapeutics, Inc. stock for Q1 2020, down 57% quarter-over-quarter.
  • 17 funds opened new Stemline Therapeutics, Inc. positions in Q1 2020 and 20 closed out, a net change of -3 holders.
  • The largest Stemline Therapeutics, Inc. buyer in Q1 2020 was Clearline Capital, an estimated $6.92M added.
  • The largest Stemline Therapeutics, Inc. seller in Q1 2020 was AllianceBernstein, an estimated $11.7M sold.

Based on aggregated 13F filings for Q1 2020.